
Esteban Gustave
Analyst Intern
Heineken Sparkles, Verbio Accelerates While Dassault Systèmes Loses Its Shine
Gerresheimer plunges amid accounting violations, Dassault Systèmes loses ground after lackluster results, while Siemens Energy triples its profit driven by gas turbines and Ahold Delhaize benefits from a surge in net income. On the recommendations front, Deutsche Bank and Berenberg boost Verbio and Wacker Chemie by moving them to buy.
February 11, 2026 at 04:40 am
Kering Restitches Its Course, Philips Rekindles Growth, Ionos Loses Signal
The luxury sector is striving to regain its luster with Kering, buoyed by a less deteriorated year-end and hopes for a recovery at Gucci, while Philips benefits from a return to profit and clearer targets for 2026. Technology stocks remain volatile, with Ionos and TeamViewer suffering from AI-related doubts, as several European stocks are stirred by changes in recommendations, from Bittium to 1&1 AG.
February 10, 2026 at 05:31 am
Stellantis Skids Off Track, Vinci Accelerates
Stellantis suffers a harsh penalty after a poorly received strategic shift, dragging the entire automotive sector down with it. Vinci and Kongsberg benefit from a reassuring flow of earnings reports, while recommendation changes stir up Nemetschek and Kering.
February 06, 2026 at 04:36 am
Pileup at Volvo, Nordic Semiconductor and Rational take the fast lane
Nordic Semiconductor is in the spotlight after returning to profitability, while Rational and Tonies extend their momentum after strong reports. By contrast, Volvo Cars is absorbing a brutal market disappointment, weighed down by deteriorating performance and a very cautious tone. Recommendation changes also hit Lundbeck and Sodexo, while BNP Paribas remains supported.
February 05, 2026 at 04:32 am
Asset Sale at AMS-Osram, Takeover Bid for Beazley, Novo Nordisk Hit by a Sledgehammer
AMS-Osram and Beazley are lifting the tape after announcements of an asset sale and a takeover bid, while Wendel is being applauded for its exit from Stahl. Novo Nordisk is taking a brutal hit from its 2026 outlook, while Boliden and Demant react to a string of broker tweaks.
February 04, 2026 at 04:48 am
Evotec and BioGaia lift biotech, Vitrolife misses on diagnostics
The session is taking shape around biotech flows, led by Evotec and BioGaia, while financials find fresh momentum via Amundi. Margin pressure continues to weigh on industrials, and cyclical names like Pandora or Schaeffler are seeing more defensive positioning.
February 03, 2026 at 04:35 am
Aubay Set for Gains, Remy Adds Punch, SAP Stumbles on Outlook
Aubay and DWS are in demand after raising targets and offering greater visibility. Spirits stocks are regaining momentum, with Rémy Cointreau pulling Pernod Ricard higher thanks to a recovery in the US market. In contrast, SAP, Intrum, and Paradox are punished, while Nokia, Interroll, and Givaudan suffer from a harsher reading of their results.
January 29, 2026 at 04:49 am
Siegfried Raises the Stakes, Crédit Agricole Builds Momentum... Dr. Martens Stumbles
Siegfried is in strong demand following an external growth operation, while several stocks find support from solid earnings or shareholder-friendly decisions, such as Sage Group or Prudential. Conversely, Dr. Martens and Getinge are sharply out of favor, as their operational updates still leave too many unanswered questions.
January 27, 2026 at 04:43 am
Discover our authors
Chief Editor
Journalist
Analyst
Analyst
Analyst
- Stock Market
- Our authors
- Esteban Gustave


























